Laronde Aims To Advance Its eRNA Therapies In Eight Weeks, And Has $440m To Help

The Flagship Pioneering-founded start-up will build a “Gigabase Factory” to go from idea to in vivo proof of concept within eight weeks by rapidly manufacturing and running preclinical tests for multiple constructs at once.